BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15048964)

  • 1. Fine-needle aspiration cytology of blastic natural killer-cell lymphoma (CD4+ CD56+ hematodermic neoplasm).
    Wu HH; Ren R; Roepke JE
    Diagn Cytopathol; 2004 Apr; 30(4):268-70. PubMed ID: 15048964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
    Weaver J; Hsi ED
    J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine needle aspiration cytology of CD56-positive natural killer/T-cell lymphoma of soft tissue.
    Cho EY; Gong G; Khang SK; Kang YK; Huh J
    Cancer; 2002 Dec; 96(6):344-50. PubMed ID: 12478682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal extranodal NK/T-cell lymphoma diagnosed by fine-needle aspiration and cerebrospinal fluid cytology and immunophenotyping: a case report.
    Dunning KK; Wudhikarn K; Safo AO; Holman CJ; McKenna RW; Pambuccian SE
    Diagn Cytopathol; 2009 Sep; 37(9):686-95. PubMed ID: 19373919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
    Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
    J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
    Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
    Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; MaynadiƩ M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
    Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
    Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+/CD56+ hematodermic neoplasm: blastic NK cell lymphoma in a 6-year-old child: report of a case and review of literature.
    Eguaras AV; Lo RW; Veloso JD; Tan VG; Enriquez ML; Del Rosario ML
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):766-9. PubMed ID: 17984695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
    Liu XY; Atkins RC; Feusner JH; Rowland JM
    Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
    Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
    Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
    Herling M; Jones D
    Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
    Farinola MA; Weir EG; Ali SZ
    Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell neoplasms.
    Liang X; Graham DK
    Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report.
    Wang P; Wang Z; Kong Y; Xu A
    Int J Dermatol; 2009 Jan; 48(1):62-5. PubMed ID: 19126053
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine-needle aspiration of a primary mediastinal large B-cell lymphoma: a case report with cytologic, histologic, and flow cytometric considerations.
    Hoda RS; Picklesimer L; Green KM; Self S
    Diagn Cytopathol; 2005 Jun; 32(6):370-3. PubMed ID: 15880713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.